Rajat Walia
Expertise in
24
conditions

Dr. Rajat Walia

Pulmonary Medicine | Transplant Surgery
Sjhmc Physician Services
3555 S Val Vista Dr, 
Gilbert, AZ 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
24
conditions
Sjhmc Physician Services
3555 S Val Vista Dr, 
Gilbert, AZ 

Overview

The Center for Thoracic Disease and Transplantation at the Heart & Lung Institute believes in treating all patients with dignity and respect. Using a multidisciplinary approach, the Center works to diagnose and treat some of the most complex thoracic and esophageal diseases in the Southwest through a team of physicians who provide patients with a plan of care. Patients receive treatment with state-of-the-art technology to ensure a full range of treatment options.We offer treatment and care in accordance with national guidelines.

Dr. Walia is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Lung Transplant, and Tissue Biopsy.

Dr. Walia is board certified in Internal Medicine (Sub: Critical Care Medicine), Internal Medicine, and Internal Medicine (Sub: Pulmonary Disease). He is actively involved in clinical research, co-authoring 97 peer reviewed articles and participating in 6 clinical trials. Dr. Walia is currently accepting new patients.

Specialties

Pulmonary Medicine
Transplant Surgery

Licenses

Critical Care Medicine in AZ

Board Certifications

Internal Medicine (Sub: Critical Care Medicine)
Internal Medicine
Internal Medicine (Sub: Pulmonary Disease)

Fellowships

University of Flordia, College of Medicine

Hospital Affiliations

Dignity Health St. Joseph's Hospital And Medical Center
St Josephs Hospital And Medical Center
Mercy Gilbert Medical Center
Banner Desert Medical Center
Honor Health John C. Lincoln Medical Center
Chandler Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

SJHMC PHYSICIAN SERVICES
3555 S Val Vista Dr, Gilbert, AZ 85297
Other Locations
SJHMC PHYSICIAN SERVICES
500 W Thomas Rd, 680 Dhmg St Joseph's Pelvic Pain And Surg, Phoenix, AZ 85013

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Interstitial Lung Disease Prospective Outcomes (IPF-PRO/ILD-PRO) Registry
Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Interstitial Lung Disease Prospective Outcomes (IPF-PRO/ILD-PRO) Registry
Enrollment Status: Recruiting
Publish Date: August 12, 2026
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
Enrollment Status: Active_not_recruiting
Publish Date: June 23, 2026
Intervention Type: Biological, Other
Study Drug: Prolastin C
Study Phase: Phase 3
Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Enrollment Status: Active_not_recruiting
Publish Date: April 06, 2026
Intervention Type: Combination product, Other
Study Drug: Extracorporeal Photopheresis (ECP)
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Pulmonary Fibrosis Foundation Patient Registry
Pulmonary Fibrosis Foundation Patient Registry
Enrollment Status: Completed
Publish Date: July 07, 2023
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

97 Total Publications

Impact of lung allocation policy reforms on center volume redistribution and survival after lung transplantation.
Impact of lung allocation policy reforms on center volume redistribution and survival after lung transplantation.
Journal: JHLT open
Published: August 26, 2026
Similar Doctors
Expertise in
5
conditions
Dr. Raymond L. Heilman
Transplant Surgery
Expertise in
5
conditions
Dr. Raymond L. Heilman
Transplant Surgery
Referral may be required

AZ - Transplant Kidney

5777 E Mayo Blvd, 
Phoenix, AZ 
 (28.3 miles away)
480-878-0009
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Raymond Heilman is a Transplant Surgeon practicing medicine in Phoenix, Arizona. Dr. Heilman is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Polycystic Kidney Disease, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Heilman is currently accepting new patients.

Expertise in
21
conditions
Dr. Thomas J. Slobig
Pulmonary Medicine
Expertise in
21
conditions
Dr. Thomas J. Slobig
Pulmonary Medicine
Referral may be required

Desert Pulmonary & Sleep Consultants PLC.

3303 E Baseline Rd Ste 208, 
Gilbert, AZ 
 (5.2 miles away)
480-962-1650
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Slobig is a Pulmonary Medicine provider practicing medicine in Gilbert, Arizona. Dr. Slobig is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Bronchiolitis Obliterans, Industrial Bronchitis, Bronchitis, and Tracheitis. Dr. Slobig is currently accepting new patients.

Expertise in
2
conditions
Dr. Ashwini Arjuna
Transplant Surgery
Expertise in
2
conditions
Dr. Ashwini Arjuna
Transplant Surgery
Referral may be required
Before you request

Dignity Health Norton Thoracic Institute

500 W Thomas Rd, Ste 500, 
Phoenix, AZ 
 (23.2 miles away)
602-406-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

My mission, along with the Dignity Health Medical Group, is to focus on innovative clinical care and the pursuit of excellence through scholarly activities. This allows me to provide patients with state-of-the-art patient services and exceptional patient experiences. Dr. Arjuna is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Lung Nodules, Emphysema, Lung Transplant, and Heart Transplant. Dr. Arjuna is board certified in Internal Medicine (Sub: Critical Care Medicine), Internal Medicine, and Internal Medicine (Sub: Pulmonary Disease). Dr. Arjuna is currently accepting new patients.

Frequently Asked Questions about Dr. Rajat Walia

How do I make an appointment with Dr. Rajat Walia?

You can book an appointment with Dr. Rajat Walia by calling their office at 480-728-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rajat Walia a top-rated expert for Lung Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rajat Walia is classified as an Elite expert for Lung Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rajat Walia specialize in?

While Dr. Rajat Walia is a Pulmonary Medicine, they have specific expertise in Lung Transplant, Pulmonary Fibrosis, and Idiopathic Pulmonary Fibrosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Rajat Walia participate in research or clinical trials?

Yes. Dr. Rajat Walia has published 97 articles and abstracts on conditions like Lung Transplant. You can view a list of Dr. Rajat Walia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rajat Walia accept my insurance?

Dr. Rajat Walia accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 480-728-8000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Walia's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 11 Advanced Conditions
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile